Abstract:The emergence of the aggregation-induced emission (AIE) concept significantly changes the cognition of the scientific community toward classic photophysical phenomena. More importantly, the AIE phenomenon has brought huge opportunities for the analysis of bioactive species, the monitoring of complicated biological processes, and the elucidation of key physiological and pathological behaviors. As a class of promising luminescent materials, AIE luminogens (AIEgens) are weakly or non-emissive in the form of isolated molecular species but emit particularly strong fluorescence in the aggregated and solid states. Motivated by the prominent advantages such as high brightness, large Stokes shift, excellent photostability, and good biocompatibility, AIEgen-based bioprobes have been widely explored in the field of biomedicine. This review aims to provide a systematic summary of the developmental history and an in-depth perspective of the current landscape of AIE in the biomedical field, with an emphasis on the discussions of major working principles. The milestones of the historical development of AIE in the biomedical field are first reviewed. A total of four major research directions are then extracted, including biomacromolecule sensing (at the molecular level), in vitro cell imaging (at the cellular level), in vivo imaging (at the animal level), and cancer theranostics (at the cellular and animal levels), together with clear-cut tables showing comprehensive cases for further study. Lastly, this review is concluded by the discussions of several perspectives on future directions. It is believed that AIEgen-based bioprobes will play vital roles in the exploration of mysterious life processes by integration with various cutting-edge modalities and techniques with an ultimate goal of addressing more healthcare issues.

Aggregation-Induced Emission Luminogen: Role in Biopsy for Precision Medicine

Imaging: Conjugated Polymer Amplified Far‐Red/Near‐Infrared Fluorescence from Nanoparticles with Aggregation‐Induced Emission Characteristics for Targeted in Vivo Imaging (adv. Healthcare Mater. 3/2013)

Real-time Monitoring of Cell Apoptosis and Drug Screening Using Fluorescent Light-Up Probe with Aggregation-Induced Emission Characteristics.

Aggregation‐induced Emission Based Fluorogens for Mitochondria‐targeted Tumor Imaging and Theranostics

Aggregation-induced red-NIR emission organic nanoparticles as effective and photostable fluorescent probes for bioimaging

Aggregation-induced Emission Luminogen for Specific Identification of Malignant Tumour in Vivo

Aggregation‐induced Emission Luminogens for in Vivo Molecular Imaging and Theranostics in Cancer

Aggregation Induced Emission Based Luminogenic (AIEgenic) Probes for the Biomarker Detection

Aggregation-induced emission luminogens for assisted cancer surgery

Aggregation-Induced Emission (AIE), Life and Health

Aggregation-Induced Emission: A Trailblazing Journey to the Field of Biomedicine

Intracellularly Manipulable Aggregation of the Aggregation-Induced Emission Luminogens

Recent advances of aggregation-induced emission materials for fluorescence image-guided surgery

Fluorescent probes for the detection of disease-associated biomarkers

The Aggregation Induced Emission Probe of Detecting Enhanced Permeation and Retention Effects is Structured for Evaluating the Applicability of Nanotherapy to Different Tumor Individuals.

Aggregation-induced emission luminescence for angiography and atherosclerotic diagnosis

A Near-Infrared Fluorescent Probe With Assembly/Aggregation-Induced Retention Effect for Specific Diagnosis of Metastasis and Image-Guided Surgery in Breast Cancer

Aggregation-Induced Bioprobe for Plasma Membrane-Specific Imaging and Photodynamic Cancer Cell Ablation

Aggregation‐Induced Emission Luminogens with Photoresponsive Behaviors for Biomedical Applications

Aggregation-induced emission luminogens for image-guided surgery in non-human primates

Practicable Applications of Aggregation‐Induced Emission with Biomedical Perspective